Maltesh is a Masters Graduate from London School of Economics with nearly 20 years of experience across Investment Banks, IT and Manufacturing Firms. Prior to starting Supercraft3D, he worked with Wipro for 10 years, with last six years as Head of Business Strategy. During this phase he also commenced the 3D Printing division of Wipro which was focused on design and development of parts for space & aerospace applications.

Supercraft3D, incorporated in Singapore in the year 2016, is focused on offering personalized patient specific offerings. For far too long individuals have been treated as mass produced serviceable mechanisms and the goal is to bring about a profound change in how healthcare is fostered.

The advent of 3D Printing (more specifically Additive Manufacturing), has made it appropriate to pursue the vision. Supercraft3D is the one of the first companies in the world that is offering patient specific pre & post surgical models (as against 2D monochromatic images), as well as customized surgical guides and smart implants using 3D Printing technology. They work with various doctors to understand the specific challenges faced during surgery and post-surgical recovery. The teams have developed profound understanding of automation of diagnostic imaging coupled with image-guided surgical solutions. They have also been able to accumulate intellectual property across bio-compatible materials and processes.

• At Additive Minds since 2017 Application Development Consultant
• At EOS since 2012 as Quality Engineer
• R&D in Laser Process Technology
• QA in Automotive and Medical
• Diploma in industrial engineering and mechanical engineering
• At EOS since 2012 in Application Department
• Development medical applications with:
  • Johnson & Johnson, Zimmer Biomet, Smith & Nephew and B. Braun
• Capability studies for additive manufactured Ti-implants
• R&D in Laser Surface Threatment for medical applications
• Diploma in industrial engineering and mechanical engineering

Lim Jing is the Chief Technology Officer at Osteopore International Pte Ltd, a Singapore medical device manufacturer of biomimetic, bioresorbable implants.

Lim Jing was trained as a Mechanical Engineer at the National University of Singapore, where he obtained his Masters (by research), with specialization in biomechanics and a focus on materials science. Thereafter, he obtained his PhD in Bioengineering from Nanyang Technological University, focusing on the development of bioactive materials for tissue engineering and regenerative medicine.

After graduation, he began work in Osteopore as a Product Development Engineer. His main responsibilities include identification and translation of new technology, and regulatory affairs.

As Head of the Johnson & Johnson 3D Printing Center of Excellence, Sam Onukuri is responsible for integrating 3D printing technology across the J&J Enterprise. He and his team of dedicated engineers drive new materials, processes and software technologies to evolve the business model from what has historically been a product-orientated to a solutions-orientated business model at point of care.  Sam works closely with J&J leaders in Supply Chain, R&D, Commercial, Quality, Regulatory, Legal, and IT across all segments to execute multiple front-end pipelines of technologies related to 3D printing and netshape technologies.

Developing a network of over 50 external partnerships, J&J is emerging as one of the leaders in 3D printing resulting in product design freedom, consumer and patient-specific product personalization, speed to market, supply chain transformation and materials innovation.

Sam has over 25 years of experience in medical devices and an extensive background as a metallurgist and in material sciences. Other J&J roles include Advanced/Front-end Technology leadership for J&J Medical Device and Senior Fellow Engineer within the Ethicon family of companies. Prior to J&J, Sam worked at General Electric and Baxter Healthcare. He is based in Cincinnati, Ohio at the Ethicon Campus.

Dr. Srinivas Bhylahalli is the Vice President of Business development at Anatomics responsible for growing the business in Asia. He developed extensive experience in medical device innovation, licensing, technology transfer and start-ups in his roles at NUS Enterprise and ETPL, the IP management and commercialization offices of the National university of Singapore and Agency for Science technology and Research respectively in Singapore. He holds a PhD from the University of Cologne and MBA from Vlerick Business School.

Huub van Esbroeck is one of the founders of Structo3D, a Singapore-based technology company with equipment and materials for dental and orthodontic additive manufacturing. Originally from the Netherlands, Huub studied mechanical engineering at the National University of Singapore and founded Structo3D together with three fellow graduates in 2014. They have since grown the company to a 30-strong team and sold their industrial-grade printers to dental labs and clinics across four continents.

Director, Cardiomyopathy and Heart Function Programme

Department of Paediatric Subspecialties, KK Women’s and Children’s Hospital

Medical Director, National Paediatric Heart Transplant and Mechanical Cardiac Support Programme, Singapore

Adj Asst Professor of Paediatrics, Yong Loo Lin School of Medicine, NUS

Dr Chen Ching Kit is a senior consultant paediatric cardiologist at KK Women’s and Children’s Hospital (KKH). He underwent two years of fellowship in paediatric heart failure and heart transplantation at the Hospital for Sick Children in Toronto, Canada.  His other areas of interest and expertise include exercise echocardiography, foetal cardiology and 3D printing of heart models.  A recipient of the Philip Witchel Memorial Research Fellowship in Pediatric Heart Failure 2013 (Canada), his current research interests include dilated cardiomyopathy, exercise echocardiography in cardiomyopathy and congenital heart diseases, and the impact of de novo anti-HLA antibodies in paediatric heart transplantation.

Howard Wood is the Co-founder & Director of 3D Printing Studios Asia and 3D Printing Studios Australia.

Howard has extensive experience with additive manufacturing having been involved in the industry for over 11 years. He has been involved with not only setting up three 3D Printing Studios but helping hundreds of students and academics to understand the technologies available via workshops and training clinics.  Over the last 11 years he has been involved with many medical research projects, some of these have involved helping a polio sufferer to walk by designing a 3D printed support system, producing a new infant respirator that seals around the patients face, medical models produced from CT and MRI scans used in preoperative surgical planning, surgical aids used in the operating theatre and prosthetics.

He is currently involved with many innovative products that are still in the confidential stage. This has given him a unique insight into how additive manufacturing (3D Printing) will aid the medical profession in the coming years.

Howard has also presented at exhibitions / forums on behalf of medical companies and business industry groups.

Juzar Motiwalla is a Co-Founder at Anquan, a cybersecurity and blockchain venture.

He was a venture capitalist responsible for global investments, and prior to that he was the CEO of a computer research lab in Singapore, that spawned multiple ventures and joint R&D Centers with Apple, IBM and Johns Hopkins University.

He has board-level experience with global technology start-ups. M&A exits valued at more than US$400m were secured for select companies he was involved with as Board Member/investor.

Juzar Motiwalla has a PhD in Engineering from the University of Wisconsin –
Madison.

Dr. Lye is the Director of Business Development (Future Health Care) at the NTUitive Pte Ltd, the technology transfer arm of the Nanyang Technological University in Singapore.  He is also the CEO of SysteMED Private Limited, a medical technology incubator wholly owned by NTU, and was a founder-partner at Nairos LLC, a medtech consulting firm.  Prior to Nairos, Dr. Lye was CTO-founder of Setagon, Inc., a startup which developed several proprietary stent technologies, including a metallic nanoporous surface modification for medical devices such as coronary stents. Setagon obtained over US$5.5 million in venture financing and was acquired by Medtronic. Whye-Kei is the primary inventor of the acquired technology and has over 28 patents/patent applications.  His technical experience includes work in the fields of nanoscale materials, micro-electromechanical systems, and biological nanosystems.  He has a B.Sc. (Honors) from the California Institute of Technology, and a PhD from Yale University.

Prof SH Teoh received his B Eng (1st Hons) and PhD from Materials Engineering Department, Monash University, Australia in 1978 and 1982 respectively. He is presently Professor and Chair, School of Chemical and Biomedical Engineering and joint appointment Lee Kong Chian School of Medicine, NTU. He is also a Fellow of the Academy of Engineers Singapore. While he was at the National University of Singapore (NUS) (1982-2012), he was Director, Laboratory for Biomedical Engineering and Centre of Biomedical Materials & Applications (BIOMAT) at the Department of Mechanical Engineering and Executive Member of the NUS Tissue Engineering Program. He chaired the NUS Graduate Bioengineering Programme (GPBE) from 1999 to 2005 attracted one of the best cohort and most talented group of graduate students in bioengineering who found jobs in top US universities and in China.

Prof Teoh’s main field of research is at the interface of two or more interdisciplinary fields such as in biomaterials and tissue engineering, applying the principles of materials science and engineering to solve unmet needs in medicine. He is well known for his outstanding contribution to the 3D bioresorbable scaffolds for bone. His leadership style and cutting edge translational biomedical engineering research (for example the numerous first in man for bone tissue engineering using 3D printed scaffolds and stem cells), have inspired many and helped NTU to become the number 1 ranked (QS ranking 2018) in Asia. Prof Teoh contributes significantly to professional bodies. He spun off two companies namely Osteopore (scaffolds for bone tissue engineering) and QuinXcel Tech (bioreactor). He presently serves as the President and Chairman Board of Directors of Osteopore International presently. It is here that he guided the company to obtain FDA approval and CE mark and in the marketing and distribution of the scaffolds worldwide. The scaffolds have now been implanted successfully in more than 1000 patients.

Sheryl CHEN is Head, Biomedical Sciences of the Singapore Economic Development Board (EDB).  She oversees the Medical Technology group and is responsible for industry development across the medical devices, life science instruments and diagnostics sub-sectors.  Sheryl was previously based in EDB’s Chicago Centre overseeing the Midwest catchment and promoted investments from industries including Biomedical Sciences, Consumer Businesses (Food and Nutrition), Natural Resources, and Transport Engineering (Aerospace).   Prior to that, she was part of the Medical Technology group and the International Organisations Programme Office in EDB. Sheryl graduated with a Bachelors of Science (Engineering) degree from Duke University.

Professor JY Jeng is the only one has been served in University (Professor and administrative positions), private sector and public diplomatic experience in Taiwan. He is the 3D Printing Fellow Professor of XYZ Printing Inc. He is also the Founder and President of Taiwan 3D Printing Association and the Consultant to SAS Wafer Taiwan. He was on leave from Taiwan Tech to serve as the Diplomatic Director of Science and Technology Division in Taipei Moscow Representative Office in Moscow during Jan. 2010- July 2012, and to establish and serve as the Director General of Teco Group Research Institute Taiwan during 2005-2007. He was the Founder of EU FP7 National Contact Point Taiwan in 2008. He graduated from National Cheng Kung University in 1985 in Tainan Taiwan for the engineering bachelor degree. And then he gained the Advanced Manufacturing Technology MSc from The University of Manchester Institute of Science and Technology in 1990, and Laser Material Processing PhD from The University of Liverpool in 1992 UK. He was also the visiting scholar in UC Santa Barbara USA in 2002 and The Cambridge University UK in 2008.

David WONG is Head/Additive Manufacturing Innnovation Centre (AMiC) at Nanyang Polytechnic. He leads the overall AM capability development, training, industry & technology collaborations and operation of the Centre, which was jointly set-up by Singapore Economic Development Board and Nanyang Polytechnic as an integral part of the national AM Development Ecosystem to help to drive, grow and sustain AM industry adoption and transformation.

As an early mover in AM, David pioneered the capability development and infusion of AM to his polytechnic’s programmes and have been working collaboratively with our industry for more than 20 years under the Rapid Prototyping Centre (RPC), the predecessor for AMiC, in providing  metal & plastic AM  solutions, from rapid prototyping & tooling, fixtures and manufacturing to customization and re-designed for AM.

David received his MSc (Mfg. Syst Engrg) from Cranfield University (UK) and MBA from NUS.

Dr Lars Neumann is industry and application manager for medical additive manufacturing with TRUMPF.

Lars received his doctoral degree in 2012 in Physics from ICFO – The Institute of Photonic Sciences in Barcelona. After his doctoral degree, Lars moved to Germany and engaged in the creation and optimisation of R&D project and process management in the automobile industry. Curious for new technologies, Lars soon became interested in additive manufacturing. He explored the opportunities of medical additive manufacturing as a product manager at Materialise’s headquarters in Belgium. Later he relocated to Materialise’s Shanghai office where he headed the medical team as sales manager. Lars is now with TRUMPF’s additive manufacturing unit and based in Germany’s Stuttgart. At TRUMPF, he is responsible for customers of TRUMPF’s TruPrint platform in the medical device industry.

-Founded NSI with Shane Chesson in 2014

-Hian serves on the board of Chope, Zimplistic, Love, Bonito, Grain and FinAccel

-Founder of AFC, a 24-hour pay TV channel, sold to US media giant, Scripps Interactive in Apr 2013 for US$66 million. Raised over US$20 million of VC financing for AFC “Winner of the Best performing investment by Singapore VC” Award

-Previously, Advisor to Infocomm Investments, VC arm of IDA

-Entrepreneur-in-Residence at INSEAD in Singapore

-Formerly with Solomon Smith Barney TMT Investment Banking-MBA from INSEAD Singapore, Law degree from Trinity College, Oxford

Language: English, ??

Interests: Cooking

Goh Khoon Seng is CEO of Osteopore International Pte Ltd, and Adjunct Associate Professor at Nanyang Technological University, School of Chemical and Bioengineering.  He obtained his Masters in Engineering from the National University of Singapore, and Post-Graduate Diploma (Marketing) from Chartered Institute of Marketing, UK.  He has 30 years’ experience in the medical device industry with positions in research & development, manufacturing, marketing, regional business development and management.  He has worked with start-up (Pacific Biomedical Pte Ltd), and leading multi-national corporations (Medtronic Inc, Edwards Lifesciences LLC).

Osteopore International Pte Ltd is the leading company in Regenerative Medical Devices that utilizes 3-D printing to manufacture implantable devices with biomimetic microstructures for regeneration on bone tissues, cartilage, and soft tissues.  Our products has USFDA 510K for craniofacial application since 2006 and CE Mark in 2009 & 2017, and has published 10-year follow-up with successful outcome.

Matthew Waterhouse is CEO of 3D Metalforge, the sister company of 3D Matters that operates one of Asia’s leading Additive Manufacturing Centre (AMC) dedicated to providing industry standard, cost-effective end-to-end metal printing. Matthew built his career as a globally accomplished senior executive managing senior operational teams for over two decades – including stints in top-level management consulting as Associate Principal with McKinsey & Co., and COO for Keppel Integrated Engineering. He has worked extensively across Asia Pacific, Australia and Middle East with functional expertise in project management, EPC projects, planning, oil and gas and waste water EPC projects, large scale construction and shipping operations. His in-depth experience also encompasses leadership capability building, front line operations improvement and project controls including planning and risk management.

Wim Michiels graduated as a M.Sc. in Mechanical Engineering from the Catholic University of Leuven in 1992. After finishing a research project at the university, he traveled for a while throughout South-East Asia and went on to live in Surinam and Thailand, where he pursed his ideals to contribute to development collaboration. Wim now works with Materialise since 1999, first as international sales manager for the Materialise prototyping service bureau, then as General Manager Asia Pacific, operating out of the Materialise Malaysia branch office.

In 2006 Wim returned to the company’s headquarters, to start a new assignment as Division Manager for Materialise’s Software division. Since 2011 he became Executive Vice President to the company, focusing mainly in business development. Finally, Wim came back to Malaysia in September 2012 to become CEO for Materialise Malaysia Sdn. Bhd. and to surther support the Asia Pacific market as corporate VP.

He is passionate about Additive Manufacturing technology, and sees it as a company mission and personal target to bring game changing technology to as wide an audience as possible for a better and healthier world.

Dr Gavin O’Neill

Consultant, Division of Musculoskeletal Trauma Surgery & Division of Hip & Knee

Associate Programme Director, NUHS Orthopaedic Surgery Residency Programme

Core Faculty, NUHS Orthopaedic Surgery Residency Programme

Dr. Gavin O’Neill graduated from University of Dundee, UK in 2002. His specialist Orthopaedic training was in Glasgow, obtaining his FRCS (Trauma & Orthopaedic) in 2010. He was Fellowship trained in Trauma and Lower Limb Reconstruction at The Royal Melbourne Hospital, Australia.

Dr O’Neill specialises in all aspects of musculoskeletal trauma with a particular interest in complex peri-articular trauma, peri-prosthetic fractures and pelvic and acetabular trauma. He is an experienced primary and revision Hip and Knee replacement surgeon. He has significant experience in computer assisted surgery, sports surgery and hip arthroscopy.

He is committed to the ongoing education of pre and postgraduate students at NUHS and is a core faculty member.

Mr. Shrivastava is responsible for advancing Quintiles’ Medical Devices & Diagnostics business in Asia-Pacific. He has more than 18 years’ experience in leading business operations and clinical research projects involving medical devices, including pivotal first-in-human studies and post-marketing studies in Asia and the European Union. Prior to joining Quintiles, Mr. Shrivastava held key positions in the areas of clinical research, portfolio management and marketing and business development with Guidant Corporation and Abbott Vascular. He has extensive experience in coordinating with local regulatory bodies regarding approvals for clinical studies and to commercialize products in Asia.

Sean Looi is currently the General Manager of Creatz3D, authorised reseller of various professional 3D printers for plastic, metals & ceramics. Recently, Creatz3D has also set up two dedicated service bureaus providing 3D printing for technical ceramics as well as a service bureau focusing on medical modelling & solutions.

Despite majoring in MSc Finance, Sean decided to pursue his passion in 3D Printing and distribute 3D printing technologies in 2007. Being a strong proponent of additive manufacturing, Sean has support the industry by being a regular speaker at various events on 3D printing machines, technologies and applications.

W. Gregory Popp is a graduate of Northwestern’s Feinberg school of Medicine Orthotics and Prosthetics program.  He is the COO and Head of Education and Support at Create Orthotics and Prosthetics, a company who provides 3D printed items and supplies to the orthotic and prosthetic community.  He has contributed to the development and design of the of the new Create 1400 a 3D printer package that includes education and support designed specifically for the prosthetic community.  Create O&P partners with a number of nonprofit orthotics and prosthetic organizations to bring the benefits of additive manufacturing to the developing world.  In addition Greg is a Orthotist and Prosthetist at Mountain Orthotics and Prosthetics in Lake Placid, New York where he uses the latest innovations to provide the best and most up to date care for his patients.

Professor Jerry FUH Ying Hsi, has devoted himself to the research of additive manufacturing (AM) processes or 3D Printing (3DP) since 1995. He is currently a Professor in the Department of Mechanical Engineering, NUS and also the Co-Director of NUS Centre of Additive Manufacturing since 2016.  At NUS, he and his colleagues have established the NUS’s AM/3DP research programme and set up advanced AM/3DP laboratories through several research grants and industrial collaborations. He has published over 300 technical papers in design and manufacturing related areas. As a result of his research on AM/3DP, 60 international-refereed papers were published related to the AM processes and materials. A book entitled “Laser-Induced Materials and Processes for Rapid Prototyping” was published by Kluwer Academic, MA in 2001.  In 2005, together with his AM research team, he received the IES Prestigious Engineering Achievement Award for “Development of Rapid Prototyping Technologies for Precision and Biomedical Engineering” from the Institute of Engineers, Singapore (IES) in recognition of outstanding engineering skills which have made notable contributions to progress in engineering in Singapore.

Eric Loh has more than 20 years of experience in the medical device industry. Most notably, Eric played significant roles in developing Biosensors International, an early-stage cardiovascular device company, to a successful, publicly traded company on the Singapore Stock Exchange. In his role as the Managing Director of Biosensors, he oversaw the establishment of a joint venture operation in China that resulted in Biosensors’ successful entry into the fast-growing Chinese markets. He also led successful sales and marketing efforts and commercialized Biosensors’ products in many other markets in Asia Pacific while managing two manufacturing facilities in Singapore.

In 2005, Eric was involved with the company’s IPO on the Singapore Stock Exchange. He continued to lead the company’s corporate development and was involved in several M&A transactions that brought value to the company’s progress.

After leaving Biosensors, Eric was the CEO of another start-up, EPI Mobile Health, where he achieved regulatory approvals of the novel mobile ECG device from the FDA, CE, and HSA that enabled the commercialization of the products in key markets in Asia.

Eric holds an M.Sc., Medical Engineering, and B.Eng. (Hons.), both from the National University of Singapore; is a graduate of an Executive MBA program affiliated with the Helsinki School of Economics; and is a CFA charterholder.

A/Prof Wilson Wang is Head of Orthopaedic Surgery, National University Hospital (NUH) and Yong Loo Lin School of Medicine, National University of Singapore. He is also the Head & Senior Consultant of the Division of Hip and Knee Surgery. He completed his medical degree with distinctions at the University of London, and was the Girdlestone Scholar at the University of Oxford for his PhD degree. His subspeciality fellowship training in joint replacement and reconstruction was at the renowned Nuffield Orthopaedic Centre in Oxford, UK. He specializes in primary and complex knee and hip replacement surgery and as well as other forms of joint reconstruction. He also leads an active and prize-winning programme in orthopaedic research, with special interest in implant science and technology.